Clinical trial
An Investigation of the Effect of High Dose s.c. Semaglutide on Gastric Emptying in Participants With Obesity
NCT07845578 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Investigation of the Effect of High Dose s.c. Semaglutide on Gastric Emptying in Participants With Obesity
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 25, 2026
- Completion date
- September 11, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.